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Abstract We have studied the perfusion of the jejunum and
ileum in an isolated rat intestine model with flavonoids and
hydroxycinnamates and the influence of glycosylation on the
subsequent metabolism. Flavone and flavonol glucosides and
their corresponding aglycones are glucuronidated during transfer
across the rat jejunum and ileum and this glucuronidation occurs
without the need for gut microflora. Furthermore, this suggests
the presence of glycosidases as well as UDP-glucuronyl
transferase in the jejunum. In contrast, quercetin-3-glucoside
and rutin are mainly absorbed unmetabolised. The results suggest
that the more highly reducing phenolics are absorbed predomi-
nantly as glucuronides (96.5% þ 4.6) of the amount absorbed,
whereas monophenolic hydroxycinnamates and monophenolic B-
ring flavonoids are less predisposed to glucuronidation and higher
levels of aglycone (88.1% þ 10.1) are detected on absorption
through both the jejunum and ileum.
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1. Introduction
Flavonoids and hydroxycinnamates are polyphenolic phy-
tochemicals, present in abundance in fruit, vegetables, bever-
ages and grains [1]. The structure-dependent hydrogen-donat-
ing abilities of polyphenolics and their propensity for nitration
make many of these compounds powerful scavengers of reac-
tive oxygen and reactive nitrogen species [2,3]. Although epi-
demiological studies based on assessment of intake and clin-
ical endpoints have implicated a role for polyphenolic
compounds in disease prevention [4,5], their role as antioxi-
dants in vivo is still unclear. The extent of their antioxidant
potential in vivo will be dependent on the metabolism, ab-
sorption and excretion of these compounds within the body
after ingestion and the reducing properties of the resulting
metabolites.
There is much controversy as to whether natural £avonoid
glycosides can be absorbed by the gastrointestinal tract, or
whether they are hydrolysed in the small intestine prior to
absorption. A number of early studies hypothesised that £a-
vonoids would not enter the circulation, either as the natural
glycosides or as the aglycone hydrolysis products [6^9]. It was
thought that cleavage at the central heterocyclic ring by in-
testinal bacteria would occur e¡ectively destroying the anti-
oxidant properties of the compounds and generating phenolic
acid ¢ssion products [6^9]. However, recent studies have de-
tected quercetin-3-rhamnoglucoside (rutin) in the circulation
after the consumption of apple or onion [10] and in blood
plasma of individuals consuming a generally high fruit and
vegetable diet [11]. Anthocyanidin glycoside (anthocyanin) ab-
sorption has also been reported in humans [12^14]. The direct
intestinal absorption of cyanidin-3-glucoside has been de-
tected in plasma with no appearance of the aglycone after
administration to rats, although it was present in the jejunum
[15]. In addition, studies on plasma have also demonstrated
the direct absorption of cyanidin-3-glucoside in rats and in
man derived from red fruit, elderberries and blackcurrants
[15].
The purpose of this study was to investigate the absorption
and metabolism of £avones, £avonols, £avanones and their
glycosides and hydroxycinnamates in the gastrointestinal tract
by using an isolated preparation of jejunum and ileum from
the small intestine and monitoring resulting native compound,
conjugates and metabolites. Naturally occurring dietary glyco-
sides were also compared with free aglycones to investigate
the in£uence of glycosylation on the fate of these compounds.
2. Materials and methods
2.1. Materials
Flavonoids and hydroxycinnamates were obtained from Extrasyn-
thase (ZI Lyon Nord, Genay, France). Quercetin and rutin were ob-
tained from AASC (Southampton, Hampshire, UK). L-Glucuronidase
(type L-II from limpets) was purchased from Sigma (Poole, Dorset,
UK) and L-glucosidase (from almonds) was purchased from ICN
Biomedicals (Thame, Oxon, UK). HPLC grade acetonitrile and meth-
anol were purchased from Rathburn (Walkerburn, UK) and Elgstat
UHP double distilled water (18.2 6 grade) was used throughout the
study. HPLC columns were purchased from Waters (Watford, Herts.,
UK). All other reagents used were of analytical grade and obtained
from Sigma.
2.2. Absorption studies
Absorption studies were conducted using the in vitro intestinal
preparation of Fisher and Gardner [16] in which the lumen of isolated
intestine was perfused with a segmental £ow (de¢ned as perfusion of
bu¡er interspersed with bubbles of the gas mixture) of bicarbonate
bu¡er (pH 7.4) equilibrated with 95% O2 :5% CO2 and containing
28 mM glucose. The bicarbonate bu¡er consisted of Krebs bicarbon-
ate saline solution (HCO33 : 25 mM; Na
 : 143 mM; Cl3 : 133.7 mM;
K : 5.9 mM; HPO34 : 1.2 mM) containing Ca
2 (2 mM) and Mg
(1.2 mM).
Male Sprague-Dawley rats (230^260 g) were killed with pentobar-
bital sodium (90 mg/kg, i.p.) and sections of jejunum (15^30 cm long,
beginning 10 cm from the ligament of Treitz) or ileum (20^30 cm
long, ending 5 cm from the ileo-caecal junction) were cannulated
and the lumen perfused with the bu¡er described above. The segments
of intestine were then removed from the animal and suspended in a
chamber containing liquid para⁄n at 37‡C whilst maintaining the
segmental £ow of bu¡er. Before uptake experiments were conducted
the segment was perfused for 40 min in order to £ush blood from the
vasculature and to allow £uid absorption to reach a steady state.
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Thereafter, £avonoids and hydroxycinnamates, at the stated concen-
trations, were added to the bu¡er and perfused through the system, in
a single pass fashion, for up to 90 min. In some cases the bu¡er was
recirculated through the loop. During perfusion, absorbed £uid
dropped through the para⁄n to the base of the chamber and was
collected at timed intervals. Samples collected from both the jejunum
and the ileum were immediately diluted 1:4 with methanol and stored
at 370‡C until analysis.
2.3. HPLC analysis
Internal standards were added to samples (100 Wl) before analysis
by HPLC. For hydroxycinnamates the internal standard was salicylic
acid (¢nal concentration: 10 WM). For luteolin, luteolin-7-glucoside,
quercetin, quercetin-3-glucoside and rutin the internal standard was
kaempferol (10 WM). For analysis of kaempferol and its glycosides,
quercetin-3-glucoside (10 WM) was used as the internal standard. In all
cases 30 Wl was injected onto the column for analysis. The presence of
both £avonoid and hydroxycinnamate glucuronides in the gut samples
was established by treatment with L-glucuronidase, type L-II from
limpets. Incubation of samples with enzyme (1000 units) was for
120 min at 37‡C in a 0.1 M sodium phosphate bu¡er, pH 3.8. The
0.1 M phosphate bu¡er e¡ectively inhibits all sulphatase activity
which the enzyme possesses. Samples recovered from perfusion experi-
ments performed with £avonoid glycosides were also treated with
L-glucosidase (1000 U/ml; 2 h, 37‡C) in order to determine the pres-
ence of any absorbed glycosides in the samples. This was important as
the L-glucuronidase was observed to cleave glucoside bonds as well as
glucuronide bonds.
HPLC analysis to measure compound and metabolite concentra-
tions was carried out using a Waters 626 pump and 600 controller
system with an autoinjector 717 and a photodiode array detector 996
linked to the Millennium Software system. Samples were analysed by
reverse-phase HPLC using a Nova-Pak C18 column (4.6U250 mm)
(Waters Company) with 4 Wm particle size. The temperature of the
column was maintained at 30‡C. The mobile phase consisted of a
mixture of aqueous methanol (20%) in hydrochloric acid (0.1%) and
acetonitrile (MeCN) and was pumped through the column at 0.5 ml/
min. The following gradient system was used (min/% MeCN): 0/5, 10/
5, 40/50, 60/5 for detection of all £avonoids, hydroxycinnamates and
metabolites. The eluant was monitored by photodiode array detection
at 280 and 320 nm and spectra of products obtained over the 220^600
nm range. Calibration curves of the compounds were constructed
using authentic standards (0^100 WM) and in each case were found
to be linear with correlation coe⁄cients of s 0.995.
3. Results
The comparative absorption of £avonoids and their glyco-
sides across the jejunum and ileum in a rat intestinal model
was investigated just as the extents of their conjugation and
metabolism. Table 1 demonstrates the results for the di¡erent
families of phenolics studied: hydroxycinnamates, £avones,
£avonols and £avanones. The natural dietary forms of £avo-
noids studied are glycosylated in the 7-position for luteolin
and hesperetin, the 3-position for quercetin and kaempferol
and the quinic acid ester for chlorogenic acid. The original
concentration of compounds perfused is shown (in parenthe-
ses) and the cumulative concentrations of the absorbed com-
ponents are in the form of native compound, aglycone of
perfused compound and glucuronide of aglycone. Results
are expressed as nmol/20 cm jejunum (ileum)/5 Wmol perfused
compound, i.e. standardisation to the amount in the lowest
concentration perfused, for comparative purposes, but a linear
relationship between uptake and concentration perfused can-
not necessarily be assumed.
3.1. Absorption of £avones/£avonols
3.1.1. Luteolin and luteolin-7-glucoside. Luteolin was
measurable throughout the experiment when the isolated rat
jejunum was perfused with either the aglycone (Fig. 1A) or the
monoglycoside, luteolin-7-glucoside (Fig. 1B). The amounts of
luteolin recovered at each time point were similar and in-
creased in a time-dependent sigmoidal manner (Fig. 1A,B).
However, measured levels of the aglycone were small relative
to the amount of total luteolin glucuronide recovered after
perfusion with either the aglycone or its 7-glucoside (Fig.
1A,B; Table 1). Treatment with L-glucuronidase (1000 units;
37‡C, 2 h) indicated the presence of at least six di¡erent glu-
curonides which were detected by our HPLC protocol (Fig.
2). These glucuronides had closely similar retention times,
ranging from 32.0 to 38.5 min and spectral characteristics
Fig. 1. Cumulative absorption of £avonoids and their glucuronides (nmol/20 cm gut/5 Wmol perfused sample) over 90 min through isolated rat
jejunum after perfusion with (A) luteolin, (B) luteolin-7-glucoside, (C) kaempferol, (D) kaempferol-3-glucoside, (E) quercetin, (F) quercetin-3-
glucoside, (G) hesperetin. Experiments were performed as outlined in Section 2 and in the legend of Table 1. Data are plotted as the mean þ
S.E.M. of at least three separate experiments each analysed twice in duplicate. (F) Perfused compound, (b) glucuronide, (R) aglycone of per-
fused glycoside.
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which would suggest they were mono-glucuronidated at di¡er-
ent sites and possibly di- or tri-glucuronidated (Fig. 2A). Re-
coveries of both the luteolin aglycone and its glucuronides
were lower across the ileum relative to the jejunum (Table
1). Samples of the bu¡er solution containing the compounds
of interest before and after the experiment were analysed by
HPLC to ascertain that the compounds were present and
stable throughout the course of the experiment. Luteolin, lu-
teolin-7-glucoside, kaempferol and kaempferol-3-glucoside
were stable over the duration of the 90 min experiment.
3.1.2. Kaempferol and kaempferol-3-glucoside. Perfusion
of the jejunum or the ileum with kaempferol resulted in the
transfer of large amounts of kaempferol glucuronides and a
small amount of the aglycone across the gastrointestinal mem-
brane to the serosal £uid (Fig. 1C; Table 1). Levels of both
the glucuronide and the aglycone were higher when the ileum
was perfused with kaempferol compared to the jejunum (Ta-
ble 1). However, no kaempferol was detected in samples at
any time point when either the jejunum or the ileum was
perfused with kaempferol-3-glucoside, although, relatively
large amounts of kaempferol glucuronide were detected after
perfusion with kaempferol-3-glucoside (Fig. 1D). This may
have been due to the lower concentration of kaempferol-3-
glucoside to which the jejunum was exposed. Three glucuro-
nidated forms of kaempferol were detected with retention
times ranging from 33.5 to 36.0 min on perfusion with the
aglycone but only one when the 3-glucoside was perfused as
evidenced by the e¡ects of L-glucuronidase. There was no
signi¢cant loss of kaempferol or its 3-glucoside over the 90
min experimental period.
3.1.3. Quercetin, quercetin-3-glucoside and rutin. The
amount of quercetin aglycone absorbed through the isolated
rat jejunum versus time, after perfusion with quercetin, is
presented in Fig. 1E. No quercetin was detected in samples
at time points earlier than 60 min, however, small amounts
were present at later times. As with kaempferol, higher quer-
cetin levels were measurable in ileum perfused samples (Table
1). By contrast to the aglycone, relatively large amounts of
quercetin glucuronides were detected in the serosal £uid over
the 90 min perfusion time (Fig. 1E). Perfusion of the jejunum
with quercetin-3-glucoside resulted in the detection of querce-
tin-3-glucoside, the hydrolysis product quercetin as well as
quercetin glucuronides (Fig. 1F) with quercetin-3-glucoside
being the major absorbed species. In the case of rutin (querci-
trin-3-rhamnoglucoside) there was no quercetin aglycone or
glucuronide detected but rutin was detected (Table 1) suggest-
ing that hydrolysis did not occur but that the diglycoside was
absorbed in the native form. Measurement of quercetin, in
pre- and post-bu¡er samples indicated that some oxidation
of the compound may be occurring over the course of the
experiment, although quercetin-3-glucoside and rutin ap-
peared more stable.
3.2. Absorption of £avanones
3.2.1. Hesperetin and hesperidin. Perfusion of the jejunum
and ileum with hesperetin resulted in its detection at all time
points (Fig. 1G). Small amounts of glucuronide were detected
after 60 min of perfusion but the major component was the
native perfused form. In contrast, no hesperidin (hesperetin-7-
rhamnoglucoside), its hydrolysis nor glucuronidation products
were detected at any time point after perfusion with hesper-
idin (Table 1). Both compounds were stable over the course of
the experiments.
3.3. Absorption of hydroxycinnamates
The amounts of ca¡eic acid, ferulic acid, p-coumaric acid
and chlorogenic acid (nmol/20 cm gut/5 Wmol perfused com-
pound) absorbed through rat jejunum versus time are pre-
sented in Fig. 3A^D, respectively. Large amounts of ferulic
acid and p-coumaric acid aglycone were detected in gut sam-
ples cumulating after 60 min perfusion (Fig. 3A,B, respec-
tively). However, the amounts of ca¡eic acid (Fig. 3C) and
its quinic ester, chlorogenic acid (Fig. 3D), were low at all
time points. In addition, in contrast to the £avonoids the
absorption of the hydroxycinnamates through the ileum was
much lower than that observed through the jejunum (Table
Table 1
Comparison of cumulative absorption of perfused compounds, aglycones and glucuronides absorption through isolated rat jejunum and ileum




















Ca¡eic acid (74.8) 0.695 * 1.220 1.915 0.191 ^ 0.103 0.294
Ferulic acid (76.0) 6.690 * 1.480 8.170 0.658 ^ 0.319 0.977
Chlorogenic acid (75.8) 0.115 0.000 0.000 0.115 0.028 ^ 0.000 0.028
p-coumaric acid (72.7) 3.745 * 0.000 3.745 No data No data No data No data
Quercetin (13.1) 0.185 * 7.317 7.502 0.654 ^ 3.170 3.824
Quercetin-3-glucoside (47.6) 4.283 0.492 1.419 6.194 No data No data No data No data
Rutin (67.1) 2.059 0.000 0.000 2.059 No data No data No data No data
Luteolin (87.3) 0.222 * 7.014 7.236 0.663 ^ 4.462 5.125
Luteolin-7-glucoside (81.7) 0.000 0.636 4.941 5.577 No data No data No data No data
Kaempferol (78.9) 0.062 * 9.022 9.084 3.858 ^ 15.973 19.831
Kaempferol-3-glucoside (5.5) 0.000 0.000 4.633 4.633 0.000 0.000 0.419 0.419
Hesperetin (51.6) 1.473 * 0.313 1.786 2.334 ^ 0.000 2.334
Hesperidin (hesperetin-3-
rhamnoglucoside) (50.4)
0.000 0.000 0.000 0.00 No data No data No data No data
Results are expressed as nmol/20 cm jejunum or ileum/5 Wmol perfused compound in order to standardise to the amount in the lowest concen-
tration perfused. Experiments were performed as described in Section 2. * indicates that the perfused compound is the aglycone.
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1). For example, over the 90 min perfusion period the absorp-
tion of ferulic acid through the ileum was approximately 10-
fold lower than through the jejunum (0.658 and 6.690 nmol/20
cm gut/5 Wmol perfused sample, respectively) (Table 1).
After perfusion with ca¡eic acid for 90 min two glucuro-
nides were detected in the serosal £uid throughout the experi-
ment. The levels of glucuronide detected were approximately
two-fold higher than ca¡eic acid (Table 1; Fig. 3C), the
amount of native ca¡eic acid absorbed through the jejunum
being 0.695 nmol/20 cm gut/5 Wmol perfused compound, com-
pared to the amount of ca¡eic acid glucuronides of 1.220
nmol/20 cm gut/5 Wmol perfused compound. Signi¢cant
amounts of ferulic acid glucuronide were observed (1.480
nmol/20 cm gut/5 Wmol perfused compound), however, this
was low compared to the amount of the ferulic acid itself
(6.690 nmol/20 cm gut/5 Wmol perfused compound). In con-
trast to the other hydroxycinnamates, no glucuronide of
chlorogenic acid was observed at any time point. Data for
the absorption of hydroxycinnamate glucuronides across the
ileum followed a similar pattern to that seen across the jeju-
num but was much lower (Table 1).
4. Discussion
The purpose of this study was to determine the forms in
which the £avonoids and phenolics studied are absorbed and
to obtain information on their metabolism in the small intes-
tine. In order for the glycosides luteolin-7-glucoside, kaemp-
ferol-3-glucoside, quercetin-3-glucoside and rutin to appear as
glucuronides of their aglycones, the glycosidic groups must
¢rst be cleaved by an intestinal enzyme prior to glucuronida-
tion. The studies reported here show that luteolin-7-glucoside,
kaempferol-3-glucoside and quercetin-3-glucoside are cleaved
by rat jejunal or ileal mucosa, suggesting the presence of a
glucosidase, and that a UDP glucuronyl transferase is present
glucuronidating the phenolics before e¥ux into the serosal
£uid. The ¢ndings here concerning quercetin-3- and kaemp-
ferol-3-glucosides are in contrast with the study of Day et al.
[17] describing a L-glucosidase in cell free extracts of the hu-
man small intestine hydrolysing some monoglucosides, e.g.
quercetin-4P-glucoside, naringenin-7-glucoside, but not quer-
cetin-3-glucoside, kaempferol-3-glucoside, nor the diglycosides
such as rutin and quercetin-3,4P-diglucoside. Prior to this, it
had been assumed that the glycosides could not be absorbed
from the small intestine and cleavage of the L-glycosidic bond
will not occur until the compound reaches the micro£ora of
the large intestine.
The advantage of the isolated preparation used in this study
to assess intestinal transfer of both £avonoids and hydroxy-
cinnamates and their glycosides is that serial measurements of
Fig. 2. Representative HPLC chromatogram after perfusion of isolated rat jejunum with luteolin. A: No enzyme treatment. B: Treatment with
L-glucuronidase (1000 units) for 2 h at 37‡C. Peaks at retention times of V40.7 min and V43.8 min are luteolin and kaempferol (internal
standard), respectively.
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the rate of absorption from the lumen can be made using
de¢ned intestinal segments at short intervals. In addition the
solute under study appears on the serosal surface in the same
form as if it were transferred to the mesenteric circulation.
Therefore, enterocyte metabolism of the £avonoids and hy-
droxycinnamates, as well as their rate of transfer across spe-
ci¢c gut regions, may be studied. As reported previously [16],
tissue viability in our studies was con¢rmed by the ¢nding
that £uid transfer continued at a constant rate for the 90
min collection period, and glucose concentration in the ab-
sorbed £uid was over double that initially present in the per-
fused bu¡er (65.4 þ 3.7 mM versus 28 mM [n = 5]), indicating
the ability for active solute transport. Although other intesti-
nal preparations have been used to study £avonoid uptake,
the results obtained often need to be interpreted with caution
and may explain some discrepancies of conclusions compared
to this present work. As an example, the recent report by
Crespy et al. [18] using in vivo perfused intestine compares
the concentrations of £avonoid in the in£ow and out£ow
bu¡er in order to calculate uptake of the substrate under
study. However, this method of analysis takes no account of
£uid absorption from lumen to blood which is likely to be
considerable in view of the rate of perfusion, length of intes-
tine used and the presence of glucose in the bu¡er. In contrast
to the present investigation, the failure of Crespy et al. [19] to
detect uptake of rutin is likely to have a methodological basis.
Our results suggest that the major products transferred
across the intestinal epithelium are glucuronides of the parent
aglycone or of the hydrolysed glycoside. Whether perfused
with the aglycone or the glycoside, the dominant forms
present in the serosal £uid (90^100% of total) were the glu-
curonides of kaempferol and luteolin. However, while a small
proportion of aglycone was also absorbed from perfusion
with aglycone, the native glycosides were not detected after
perfusion of the glycosides. While the same situation per-
tained for quercetin, their glycosides (the 3-monoglucoside
and the 3-rhamnoglucoside) were absorbed to a major extent
in these glycosylated forms. Indeed, previous studies have
detected rutin and quercetin-3-glucoside in human plasma
[10,11]. It has been proposed that glycoside linkages are less
stable than, for example, glucuronide linkages and might not
withstand the acidic environment of the stomach [19]. In the
case of quercetin glycosides, at least, this has been shown not
to be the case from in vivo studies.
Hydroxycinnamate absorption in the jejunum seems to be
related to the oxidisability of the compound in question. For
example, relatively high amounts of ferulic acid are absorbed
through the jejunum over the 90 min (6.69 nmol/20 cm gut/5
Wmol perfused) but only low amounts of both the catechol-
containing monophenolics ca¡eic acid (0.695 nmol/20 cm gut/
5 Wmol perfused) or its quinic ester (0.115 nmol/20 cm gut/5
Wmol perfused) are detected after exposure for the same length
of time. This di¡erence may be a result of the higher suscept-
ibility to oxidation of the two latter compounds at the intes-
Fig. 2 (continued).
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tinal epithelium wall. The extent of glucuronidation is clearly
dependent on the available hydroxyl groups. It is worthwhile
emphasising the observation that the monophenolic hydroxy-
cinnamates and the £avonoid with a substituted hydroxyl
group on the B-ring (ferulic acid, p-coumaric acid and hesper-
etin, respectively) are also less predisposed to glucuronidation
and relatively high levels of the aglycone (80^100% of total)
are detected after absorption through both the jejunum and
the ileum. On the other hand, the £avonoids studied contain-
ing a 3P,4P-ortho-dihydroxy (or catechol) B-ring were ab-
sorbed predominantly as glucuronides (88^100%), with the
exception of quercetin-3-glucoside and rutin which are ab-
sorbed as glycosides.
Bioavailability studies on catechins, quercetin (and its gly-
cosides) and other catechol-containing £avonols and £avanols
have demonstrated very low levels of the native compounds
and their conjugates both in the circulation and excreted in
the urine of both rat and man [20^23]. Studies comparing the
urinary excretion of quercetin and its glycosides after oral
versus intravenous administration to rats detect low levels of
native compounds or conjugates, suggesting that the majority
is cleaved and metabolised by the liver [23]. In contrast, the
major non-catechol containing phenolic components of the
diet, such as ferulic acid and naringenin compounds are ab-
sorbed to much greater extents as shown particularly in uri-
nary elimination studies in rat and man [12,23]. The studies
described here indicate that the total absorption of a ferulic
acid, quercetin and quercetin-3-glucoside, for example, across
the jejunum of the isolated rat intestine are reasonably com-
parable and indicate that in vivo more extensive metabolism
(especially of the more oxidizable phenolics) takes place in the
tissues, circulation and the liver after absorption across the
intestinal wall.
Glucuronidation of the £avonoids was observed to occur at
di¡erent, and possibly, multiple hydroxyl groups within the
structure. The position at which glucuronidation is occurring
will be of importance when considering the resulting anti-
oxidant potential of the absorbed glucuronides especially since
the reduction potential of the B-ring of phenolics is lower than
that of the A-ring [24]. For example, glucuronidation at 3P- or
4P-OH groups on the B-ring of £avonoids would increase the
reduction potential and therefore decrease its antioxidant ac-
tivity. However, if glucuronidation occurs at hydroxyl groups
in the A-ring of the £avonoid then the antioxidant potential
would be less in£uenced. Indeed, recent studies have identi¢ed
the 5-O-L-glucoside of catechin and epicatechin excreted in
the urine of rats post-ingestion and that this does not interfere
with their antioxidant properties [21,22]. Our perfusion studies
with luteolin are consistent with those of Shimoi et al. [25]
who studied transfer of compounds from the mucosa to the
serosal side of a rat everted intestine model. However,
although they also observed glucuronidation of luteolin and
the hydrolysis of luteolin-7-glucoside to luteolin during trans-
fer across the gut, their studies only revealed the presence of
two glucuronidated/sulphated metabolites whereas we have
identi¢ed six distinct luteolin glucuronides (Fig. 3). An inves-
tigation into what the major sites of glucuronidation are on
£avonoids, whether this glucuronidation is reversible in vivo
and how e¡ective the major absorbed glucuronides are as
antioxidants would provide valuable information about the
potential of £avonoids to act as antioxidants in vivo.
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